Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 12.21
+0.06 (0.49%)
At close: Jul 4, 2025, 2:57 PM CST
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 26.83 billion as of July 11, 2025. Its market cap has decreased by -10.90% in one year.
Market Cap
26.83B
Enterprise Value
27.11B
Revenue
5.53B
Ranking
n/a
PE Ratio
20.05
Stock Price
12.21
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 26.83B, an increase of 20.09%. That is a compound annual growth rate of 7.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 26.83B | 1.57% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 384.79B |
| Shenzhen Mindray Bio-Medical Electronics | 264.43B |
| WuXi AppTec | 200.91B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.46B |
| Aier Eye Hospital Group | 115.45B |
| Sichuan Biokin Pharmaceutical | 114.29B |
| Shanghai United Imaging Healthcare | 103.20B |
| Yunnan Baiyao Group Co.,Ltd | 99.92B |